Skip to main content
Premium Trial:

Request an Annual Quote

Veena Singh

Biocept announced that Veena Singh will be its senior vice president and senior medical director.

Singh joins Biocept, a company focused on circulating tumor cells and circulating tumor DNA biomarker analysis, from BioTheranostics, where she was the medical director. During her tenure at BioTheranostics, the firm's clinical laboratory expanded to run a range of diagnostic platforms, including  next-generation sequencing, RT-PCR and FISH. Singh also has experience navigating the regulatory and reimbursement landscape for molecular diagnostics.

Before working at BioTheranostics, Singh held a molecular genetic pathology fellowship at Cedars Sinai Medical Center in Los Angeles and an anatomic and clinical pathology residency at the University of California, San Diego. Singh is a board certified anatomic and clinical pathologist and a molecular genetic pahtologist. 

The Scan

CDC Calls Delta "Variant of Concern"

CNN reports the US Centers for Disease Control and Prevention now considers the Delta variant of SARS-CoV-2 to be a "variant of concern."

From FDA to Venture Capital

Former FDA Commissioner Stephen Hahn is taking a position at a venture capital firm, leading some ethicists to raise eyebrows, according to the Washington Post.

Consent Questions

Nature News writes that there are questions whether informed consent was obtained for some submissions to a database of Y-chromosome profiles.

Cell Studies on Multimodal Single-Cell Analysis, Coronaviruses in Bats, Urban Microbiomes

In Cell this week: approach to analyze multimodal single-cell genomic data, analysis of bat coronaviruses, and more.